Copyright
©The Author(s) 2019.
World J Hepatol. Sep 27, 2019; 11(9): 678-688
Published online Sep 27, 2019. doi: 10.4254/wjh.v11.i9.678
Published online Sep 27, 2019. doi: 10.4254/wjh.v11.i9.678
Variables1 | HCC (n = 519) |
Race | |
White | 462 (89.0) |
Black | 35 (6.8) |
Others | 22 (4.2) |
Etiology | |
HCV | 407 (78.4) |
Alcohol abuse | 194 (37.4) |
HBV | 31 (6.0) |
NAFLD | 23 (4.4) |
Cryptogenic cirrhosis | 9 (1.7) |
Alpha-fetoprotein (ng/mL) | |
< 400 | 361 (69.6) |
≥ 400 | 109 (21.0) |
Data not available | 49 (9.4) |
Child-Pugh score | |
A | 273 (52.6) |
B | 181 (34.9) |
C | 65 (12.5) |
Multifocal Tumor | |
Yes | 261 (50.3) |
No | 258 (49.7) |
Tumor size, cm | |
< 10 cm | 449 (86.5) |
≥ 10 cm | 30 (5.8) |
Data not available | 40 (7.7) |
- Citation: Freitas LBR, Longo L, Santos D, Grivicich I, Álvares-da-Silva MR. Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population. World J Hepatol 2019; 11(9): 678-688
- URL: https://www.wjgnet.com/1948-5182/full/v11/i9/678.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i9.678